Description
Meri Helleranta, PhD, MBA, is a Partner at Luxembourg-based Metl Venture Partners, which invests in European health technology companies scaling into the Indian market. An epidemiologist by training, she assesses deep-tech companies as a member of the EIC's Investment Jury, and previously spent 14 years leading health investments at the World Bank and the Inter-American Development Bank.
